Afghanistan received 500,000 doses of AztraZeneca’s COVID-19 vaccine from India on Sunday.
According to Health authorities, the vaccine is still waiting for emergency approval from the World Health Organisation before it can use them.
Ghulam Dastagir Nazari, head of the immunisation program at the health ministry said the doses would be stored in Kabul until the emergency authorisation was received, which it hoped would happen in a week.
The vaccines were produced by the Serum Institute of India (SII), which is producing the AstraZenecca/Oxford University vaccine for mid- and low-income countries.
“The (WHO) certification process is underway and hopefully it will be done in a week and we will start the vaccination process in all 34 provinces,” Nazari added.
